Opportunity
SAM #FDA-SS-26-06202026
FDA Sole Source Investigative Services Contract with Houston Police Department
Buyer
FDA Office of the Associate General Counsel for Administrative Law
Posted
June 21, 2026
Respond By
June 27, 2026
Identifier
FDA-SS-26-06202026
NAICS
922120
This notice announces the FDA's intent to award a sole source contract to the Houston Police Department for investigative services in Houston, Texas. - Agency: Food and Drug Administration (FDA), Office of Acquisition and Grant Services - Purpose: Procurement of investigative services to support FDA operations - Vendor: Houston Police Department (HPD) is the only named vendor - NAICS Code: 922120 (Police Protection) - Procurement Method: Sole source under 10 USC 2304 (c)(5), allowing awards authorized by statute - Period of Performance: 12 months from date of award - Scope: Service requirement only; no specific products, part numbers, or quantities listed - Competition: Other firms may express interest and demonstrate capability, but FDA intends to proceed with HPD unless a suitable alternative is identified - Commercial Opportunity: Potential for other qualified law enforcement agencies to respond if they can meet the requirements
Description
The Food and Drug Administration intends to make sole source awards to the following:
Houston Police Department
They are all individual contracts for investigative work.
The period of performance will be for a total of 12 months from the date of award. The NAICS code for this action is 922120. This procurement is made under the authority of 10 USC 2304 (c)(5) - authorized by statute. This is a notice of intent to issue this solicitation on a sole source basis. This notice of intent is not a solicitation for competitive proposals. Any other firms desiring consideration must fully identify their interest and capability to provide this service or submit a proposal within 7 days to the individual listed. A determination by the government not to compete the proposed contract based upon responses to this notice is solely within the discretion of the Government.
Responses to this notice must be sent via email to: Nina.Montgomery@fda.hhs.gov
This notice will close on June 27, 2026 at 10am EST.